Target intelligence / Profile preview

CCM2L antisense RNA 1 (CCM2L-AS1)

Target: CCM2L-AS1
Molecular classification: Long non-coding RNA, Other (non-coding RNA gene)

Overview

CCM2L antisense RNA 1 (CCM2L-AS1) is a gene that produces a long non-coding RNA transcript. The function, disease relevance, or regulatory impact of this lncRNA has not been characterized in peer-reviewed literature or public molecular databases, and it is not recognized as a therapeutic target. Its “antisense” designation suggests it is transcribed from the DNA strand opposite to the protein-coding CCM2L gene, but no functional association is established[5].

Beyond the preview

Go deeper on CCM2L antisense RNA 1 (CCM2L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCM2L antisense RNA 1 (CCM2L-AS1).

Explore the full profile